/

Other

/

Sobi - Swedish Orphan Biovitrum AB (publ)

Sobi - Swedish Orphan Biovitrum AB (publ)

Sobi - Swedish Orphan Biovitrum AB (publ)

Verified Nov 2026

Other

·

Gothenburg, Vaestra Goetaland County

·

Since 2009

Sobi is a Swedish biopharmaceutical company founded in 2009 and headquartered in Gothenburg, with 1,000–5,000 employees and estimated revenue of SEK 28 billion in 2025. The company develops and distributes medicines for rare and debilitating diseases, focusing on haematology, immunology, and specialty care. Sobi completed the acquisition of Arthrosi Therapeutics in February 2026 to expand its pipeline for gout treatment.

Sobi - Swedish Orphan Biovitrum AB (publ)

Verified Nov 2026

AT A GLANCE

Founded

2009

Headquarters

Gothenburg, Vaestra Goetaland County

Employees

1,000-5,000

Ownership

Sobi - Swedish Orphan Biovitrum AB (publ) at a glance

Revenue

$1-5B

Est. band

Employees

1,000-5,000

Founded

2009

Headquarters

Gothenburg, Vaestra Goetaland County

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Sobi is a Swedish biopharmaceutical company founded in 2009 and headquartered in Gothenburg, with 1,000–5,000 employees and estimated revenue of SEK 28 billion in 2025. The company develops and distributes medicines for rare and debilitating diseases, focusing on haematology, immunology, and specialty care. Sobi completed the acquisition of Arthrosi Therapeutics in February 2026 to expand its pipeline for gout treatment.

At a glance

Attribute

Detail

Founded

2009

Headquarters

Gothenburg, Vaestra Goetaland County

Employees

1,000-5,000

Revenue

$1-5B (estimated)

What Sobi - Swedish Orphan Biovitrum AB (publ) makes

Sobi's product portfolio includes treatments such as Alprolix for haemophilia B, Gamifant for hemophagocytic lymphohistiocytosis, and Synagis for prevention of respiratory syncytial virus in infants.

Latest developments

Facilities

Sobi - Swedish Orphan Biovitrum AB (publ) is headquartered in Gothenburg, Vaestra Goetaland County. Public sources also reference these locations:

Company details

In September 2026, Sobi and Innate Pharma completed a partnership agreement for the licensing of lacutamab in T-cell lymphoma, following the company's stated ambition to deliver SEK 55 billion in revenue by 2030. Sobi - Swedish Orphan Biovitrum AB (publ) was founded in 2009, has an estimated 1,000-5,000 employees, and is headquartered in Gothenburg, Vaestra Goetaland County.

Frequently asked questions

What does Sobi - Swedish Orphan Biovitrum AB (publ) do?

Sobi is a Swedish biopharmaceutical company founded in 2009 and headquartered in Gothenburg, with 1,000–5,000 employees and estimated revenue of SEK 28 billion in 2025. The company develops and distributes medicines for rare and debilitating diseases, focusing on haematology, immunology, and specialty care. Sobi completed the acquisition of Arthrosi Therapeutics in February 2026 to expand its pipeline for gout treatment.

Where is Sobi - Swedish Orphan Biovitrum AB (publ) headquartered?

Sobi - Swedish Orphan Biovitrum AB (publ) is headquartered in Gothenburg, Vaestra Goetaland County.

When was Sobi - Swedish Orphan Biovitrum AB (publ) founded?

Sobi - Swedish Orphan Biovitrum AB (publ) was founded in 2009.

How big is Sobi - Swedish Orphan Biovitrum AB (publ)?

Sobi - Swedish Orphan Biovitrum AB (publ) has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Gothenburg, Vaestra Goetaland County (HQ)Headquarters · Sweden
Gothenburg, Vaestra Goetaland County (HQ)Gothenburg, Vaestra Goetaland County, 411 38, SwedenHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.